ARS Pharmaceuticals, Inc. SPRY
2.65 USD -0.40 (-13.11%)
At closeNov 5, 2026, 4:00 PM EST
2.77 +0.12 +4.53%
After hours · Nov 5, 4:00 PM ET
2.59 Day range 3.10
2.59 52-week range 13.15
- YTD
- -77.25%
- 1 year
- -70.72%
Revenue & Expenses
Revenue by
Latest period ending Dec 31, 2025 · select a line to chart its full history
Income statement
| Fiscal year | FY 2025 Dec 31, 2025 | FY 2024 Dec 31, 2024 | FY 2023 Dec 31, 2023 | FY 2022 Dec 31, 2022 | FY 2021 Dec 31, 2021 |
|---|---|---|---|---|---|
| 84.28M | 89.15M | 30.00K | 1.32M | 5.51M | |
| 63.85M | 88.17M | 30.00K | 1.32M | 5.51M | |
| -179.45M | -3.08M | -67.52M | -35.52M | -19.45M | |
| -171.30M | 8.00M | -54.37M | -34.68M | -20.24M | |
| -1.74 | 0.08 | -0.57 | -0.87 | -0.70 |
Balance sheet
| Fiscal year | FY 2025 Dec 31, 2025 | FY 2024 Dec 31, 2024 | FY 2023 Dec 31, 2023 | FY 2022 Dec 31, 2022 | FY 2021 Dec 31, 2021 |
|---|---|---|---|---|---|
| 41.32M | 50.82M | 70.97M | 210.52M | 60.06M | |
| 327.65M | 351.15M | 233.19M | 281.44M | 61.45M | |
| 213.39M | 94.36M | 2.43M | 8.55M | 16.68M | |
| 168.51M | 69.38M | 274.00K | 481.00K | 9.03M | |
| 114.26M | 256.80M | 230.76M | 272.89M | -31.27M |
Cash flow
| Fiscal year | FY 2025 Dec 31, 2025 | FY 2024 Dec 31, 2024 | FY 2023 Dec 31, 2023 | FY 2022 Dec 31, 2022 | FY 2021 Dec 31, 2021 |
|---|---|---|---|---|---|
| -170.87M | 13.55M | -59.27M | -40.08M | -17.56M | |
| 56.77M | -106.10M | -87.18M | -199.00K | -55.00K | |
| 104.60M | 72.40M | 6.90M | 190.73M | 53.16M | |
| -339.00K | -563.00K | -175.00K | -199.00K | -55.00K | |
| -9.50M | -20.15M | -139.55M | 150.46M | 35.54M |